A Comparison of the Risk Factors and Complications Associated With Peripherally Inserted Central Catheter (Picc) and Totally Implantable Venous Access Port (Tivap) Usage in Cancer Patients
by Tanisa Goyal
Category: STEM
Abstract – "This literature review discusses and compares the risk factors and complications associated with using peripherally inserted central catheters (PICCs) and totally implantable venous access ports (TIVAPs), particularly for cancer patients.
Research related to this topic from within the last 10 years was found and reviewed. Major PICC complications identified include phlebitis, thrombosis, infections, occlusion and mechanical problems. The independent risk factors that correlate with these include drinking, prior surgery history and immunotherapy. Drinking correlated with phlebitis and thrombosis, whereas prior surgery history correlated with thrombosis, occlusion and mechanical complications.
Major TIVAP complications identified include mechanical issues, infection and occlusion. The risk factors associated with these include age, type of cancer, and adjuvant versus non-adjuvant chemotherapy treatments. Haematological head and neck, and gynecological cancers were associated with higher risk of infection. Adjuvant settings had lower risks of infection. Overall, TIVAPs were found to have a lower incidence of venous access device related complications compared to PICCs."
Research related to this topic from within the last 10 years was found and reviewed. Major PICC complications identified include phlebitis, thrombosis, infections, occlusion and mechanical problems. The independent risk factors that correlate with these include drinking, prior surgery history and immunotherapy. Drinking correlated with phlebitis and thrombosis, whereas prior surgery history correlated with thrombosis, occlusion and mechanical complications.
Major TIVAP complications identified include mechanical issues, infection and occlusion. The risk factors associated with these include age, type of cancer, and adjuvant versus non-adjuvant chemotherapy treatments. Haematological head and neck, and gynecological cancers were associated with higher risk of infection. Adjuvant settings had lower risks of infection. Overall, TIVAPs were found to have a lower incidence of venous access device related complications compared to PICCs."